svpn news
wsj.com ↗
Roche reiterated its full-year guidance and said it is prepared to launch its giredestrant breast-cancer pill later this year.
Log in or sign up to comment.
No comments yet.
← Back to stories
or login to continue
Already have an account? Log in
Log in or sign up to comment.